Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
复制标题
Eph A10修饰的pH敏感脂质体负载新型三苯基膦-多西紫杉醇缀合物,在体外和体内均具有分级靶向性和足够的抗肿瘤作用。
DOI:
10.1080/10717544.2018.1446475
复制
发表时间:
2018-11
期刊:
影响因子:
6
通讯作者:
Zhao X
中科院分区:
文献类型:
--
作者:
Zhang J;Yang C;Pan S;Shi M;Li J;Hu H;Qiao M;Chen D;Zhao X
Mitochondrial-targeting therapy was considered to be a promising approach for the efficient treatment of cancer while positive charge induced nonspecific cytotoxicity severely limits its application. To overcome this drawback, a novel mitochondria targeted conjugate triphenylphosphine-docetaxel (TD) has been synthesized successfully and incorporated it into liposomes (EPSLP/TD), which possessed excellent pH-sensitive characteristic, EphA 10 mediated active targetability as well as mitochondria-targeting capability. EPSLP/TD was characterized to have a small particle size, high-encapsulation efficiency and excellent pH-sensitive characteristic. Compared with DTX-loaded liposomes (EPSLP/DTX), EPSLP/TD possessed higher cytotoxicity against MCF-7 cell line. Mitochondrial-targeting assay demonstrated mitochondria-targeting moiety triphenylphosphine (TPP) could efficiently deliver DTX to mitochondria. Western immunoblotting assay indicated that EPSLP/TD could efficiently deliver antitumor drug to mitochondria and induce cell apoptosis via mitochondria-mediated apoptosis pathway. In vivo antitumor study demonstrated EPSLP/TD owed excellent in vivo antitumor activity. Histological assay demonstrated EPSLP/TD showed strongly apoptosis inducing effect, anti-proliferation effect and anti-angiogenesis effect. This work investigated the potential of hierarchical targeting pH-sensitive liposomes is a suitable carrier to activate mitochondria-mediated apoptosis pathway for cancer therapy.
登录
查看更多内容
DOI:
10.1016/j.jconrel.2015.08.050
发表时间:
2015-12-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Du J;Lane LA;Nie S
通讯作者:
Nie S
影响因子:
8.4
作者:
Aziz, Ayman A. Abdel;Seda, Sabry H.;Mohammed, Soha F.
通讯作者:
Mohammed, Soha F.
影响因子:
5.8
作者:
Cui, Can;Yu, Ping;Huang, Shi-Wen
通讯作者:
Huang, Shi-Wen
影响因子:
14
作者:
Li, Nan;Zhang, Cheng-Xiang;Lu, Wan-Liang
通讯作者:
Lu, Wan-Liang
影响因子:
3.5
作者:
Li, Yue;Bhindi, Ravinay;Khachigian, Levon M.
通讯作者:
Khachigian, Levon M.